Do health care providers trust product monograph information regarding use of vaccines in pregnancy? A qualitative study

Abstract

Background: In uenza immunization is recommended in pregnancy to prevent severe infections in pregnant women and newborns, yet vaccine uptake remains low. Studies suggest that cautionary language in vaccine product monographs regarding safety and use in pregnancy affects health care providers’ perceptions of vaccine safety and how they counsel pregnant women. Objective: To conduct a qualitative analysis of health care provider perceptions of the safety of inactivated in uenza vaccines and their recommendations for use in pregnancy based on product monograph language statements. Methods: Health care providers were recruited at two international health conferences and from teaching programs in Ethiopia, Ghana, Uganda, and Laos during September and October 2015. After reading the product monograph excerpts for three licensed inactivated in uenza vaccines, participants completed a ten-item online survey with quantitative and qualitative components that captured perceptions of vaccine safety. Results: Health care providers identi ed a lack of trust in manufacturers’ and product monograph information. They perceived product monograph language as ambiguous and not “up-to-date” with current evidence. Health care providers wanted product monograph language that clearly conveyed evidence for the risks and bene ts of the vaccine in an understandable manner. Conclusion: This study suggests that adopting best practices in the wording of product monographs would help to support evidence-based use of vaccines in pregnant women.